Everus (NYSE:ECG) Price Target Raised to $80.00 at Oppenheimer

Everus (NYSE:ECGFree Report) had its price objective increased by Oppenheimer from $70.00 to $80.00 in a report released on Tuesday morning,Benzinga reports. They currently have an outperform rating on the stock.

ECG has been the topic of a number of other research reports. Stifel Nicolaus raised their target price on shares of Everus from $71.00 to $78.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. Wolfe Research assumed coverage on shares of Everus in a report on Tuesday, December 3rd. They set a “peer perform” rating on the stock. Finally, DA Davidson initiated coverage on shares of Everus in a research report on Monday, November 4th. They set a “neutral” rating and a $55.00 target price for the company.

Check Out Our Latest Research Report on Everus

Everus Stock Performance

Shares of NYSE ECG opened at $69.39 on Tuesday. The stock has a fifty day moving average of $64.95. Everus has a 52 week low of $40.05 and a 52 week high of $73.73. The company has a current ratio of 1.58, a quick ratio of 1.50 and a debt-to-equity ratio of 0.47.

Everus Company Profile

(Get Free Report)

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.

Featured Articles

Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.